Tag:
ImmunoCellular Therapeutics
Latest Headlines
Latest Headlines
ImmunoCellular licenses new ovarian cancer target
ImmunoCellular Therapeutics' vaccine, ICT-140, is a cell-based vaccine in early development for the treatment of ovarian cancer.
ImmunoCellular starts Phase II trial of brain cancer vaccine
Wake Forest Baptist Medical Center is heralding its involvement in a new Phase II trial of ImmunoCellular Therapeutics ' ICT-107. The cancer vaccine, which we recently chose as one of 10 promising
ImmunoCellular gains brain cancer vax patent
Los Angeles-based biotech ImmunoCellular Therapeutics has received a patent for its glioblastoma vaccine, ICT-107. The patent, named "System and method for the treatment of cancer, including cancers
Brain cancer vax promising in PhI
A small Phase I trial of an experimental dendritic cell-based brain cancer vaccine advanced by ImmunoCellular Therapeutics (IMUC) has produced some unusually positive results. Only 16 patients
Brain cancer vax looks promising in small trial
A small Phase I trial of an experimental dendritic cell based brain cancer vaccine advanced by ImmunoCellular Therapeutics (IMUC) has produced some unusually positive results. Only 16 patients
